TriSalus Life Sciences (TLSIW) Non-Current Assets (2020 - 2026)

TriSalus Life Sciences has reported Non-Current Assets for 7 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 19.5% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (down 17.97% YoY), and the FY2025 full-year result was $3.1 million, down 6.51% from the prior year.
• Non-Current Assets for Q1 2026 stood at $2.8 million, down from $3.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $251.0 million in Q3 2022, with the low at $2.8 million in Q1 2026.
• Historically, Non-Current Assets has averaged $48.7 million across 5 years, with a median of $4.5 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets grew 0.38% — and 2023, when it plunged 98.2%.
• TriSalus Life Sciences' Non-Current Assets stood at $4.8 million in 2022, then fell by 21.86% to $3.7 million in 2023, then decreased by 11.62% to $3.3 million in 2024, then fell by 6.51% to $3.1 million in 2025, then retreated by 7.97% to $2.8 million in 2026.
• The last three Non-Current Assets figures came in at $2.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.